Cargando…

Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis

Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multip...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Gareth J., Morton, Colin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289117/
https://www.ncbi.nlm.nih.gov/pubmed/28150108
http://dx.doi.org/10.1007/s13555-016-0166-x
_version_ 1782504457849798656
author Thomas, Gareth J.
Morton, Colin A.
author_facet Thomas, Gareth J.
Morton, Colin A.
author_sort Thomas, Gareth J.
collection PubMed
description Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multiple mechanisms. We present evidence for a chemoprotective effect of NSAIDs and discuss potential mechanisms of action of COX-2 in cancer. We also discuss the challenges associated with the treatment of actinic keratosis and the factors that should be taken into consideration when selecting a treatment regimen. A range of treatments are reviewed, with an emphasis on combination therapies.
format Online
Article
Text
id pubmed-5289117
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-52891172017-02-15 Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis Thomas, Gareth J. Morton, Colin A. Dermatol Ther (Heidelb) Review Non-steroidal anti-inflammatory drugs (NSAIDs) are a chemically diverse class of drugs that target the cyclooxygenase (COX) pathway and have anti-inflammatory, analgesic, and antipyretic properties. Elevated expression of COX-2 has been associated with tumor progression in skin cancer through multiple mechanisms. We present evidence for a chemoprotective effect of NSAIDs and discuss potential mechanisms of action of COX-2 in cancer. We also discuss the challenges associated with the treatment of actinic keratosis and the factors that should be taken into consideration when selecting a treatment regimen. A range of treatments are reviewed, with an emphasis on combination therapies. Springer Healthcare 2017-02-01 /pmc/articles/PMC5289117/ /pubmed/28150108 http://dx.doi.org/10.1007/s13555-016-0166-x Text en © The Author(s) 2017 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Thomas, Gareth J.
Morton, Colin A.
Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title_full Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title_fullStr Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title_full_unstemmed Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title_short Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
title_sort cyclooxygenase in cancer prevention and treatments for actinic keratosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5289117/
https://www.ncbi.nlm.nih.gov/pubmed/28150108
http://dx.doi.org/10.1007/s13555-016-0166-x
work_keys_str_mv AT thomasgarethj cyclooxygenaseincancerpreventionandtreatmentsforactinickeratosis
AT mortoncolina cyclooxygenaseincancerpreventionandtreatmentsforactinickeratosis